Sign In

News Story

New editorial leadership at ACS flagship journal

ACS names a new editor-in-chief and editor to CA: A Cancer Journal for Clinicians, the highest-impact peer-reviewed journal in oncology.

The American Cancer Society announced changes this week to leadership at CA: A Cancer Journal for Clinicians, the organization’s flagship journal. Dr. Don Dizon, pictured at right, a researcher and professor of medicine and surgery at Brown University, joins the journal as the new editor. He will assume the role on April 1, 2023, when current editor, Dr. Ted Gansler, retires after more than 23 years at the journal. Chief Patient Officer Dr. Arif Kamal assumed the role of editor-in-chief at CA in late 2022.

The CA journal publishes the latest information about the prevention, early detection, and treatment of cancer, as well as nutrition, palliative care, survivorship, and additional topics of interest related to cancer care.

“The CA journal has a long-standing history of connecting thought leaders and clinicians through content that is timely, useful, and inclusive,” Dr. Kamal, pictured at left, said in a media release March 21. “This is thanks to dedicated editors, like Dr. Gansler, editorial board members, reviewers, contributors, and readers who position the journal as a standard bearer in the field.”

In addition to his role as chief patient officer, Dr. Kamal is also an oncologist, researcher, professor, and innovative leader at Duke University and the Duke Cancer Institute. He is nationally recognized as an expert in oncology quality assessment and palliative care and has published more than 200 peer-reviewed articles in leading medical journals.  

“Dr. Dizon brings world-renowned expertise in cancer care delivery, the oncology workforce, and health equity that will catapult the journal further into the national discourse around oncology innovation and implementation,” Dr. Kamal said. “His experience with traditional and newer dissemination routes of knowledge will ensure that the journal is responsive to the needs of all audiences, now and into the future.”

Dr. Dizon is the director of the pelvic malignancies program and hematology-oncology outpatient clinics at the Lifespan Cancer Institute, head of community outreach and engagement at the Legorreta Cancer Center, and director of medical oncology at Rhode Island Hospital. Nationally, he is the vice chair for diversity, equity, inclusion, and professional integrity at the Southwest Oncology Group or SWOG Cancer Research Network. He also is a founding member of the collaboration for outcomes using social media in oncology.

“I consider it one of the highest honors of my career to assume the role of editor at the CA journal, and to succeed Dr. Gansler who has shepherded the journal for over two decades,” Dr. Dizon said. “I do want to showcase the content beyond statistics, such as manuscripts, focusing on diversity and equity in the practice of oncology, the importance of survivorship and thriving after cancer, and the delivery of emerging standards of care across cancer disciplines. The opportunity to grow the journal's readership as a common resource for all stakeholders, including the general public, and the rich tradition of continuing to publish high-impact articles that will further our growing understanding of the science of oncology and the impact of cancer on society, is truly exciting.”

back to top